Anavex Life Sciences Corp.
AVXL· Nasdaq
AVXLAnavex Life Sciences Corp.
Filed Feb 6, 2020 · 10-Q · 37 days after period end · 0001731122-20-000103
| Metric | Q1 2020 | Q1 2019 | Q1 2018 | Q1 2017 |
|---|---|---|---|---|
| Net Income | -$6.59M | -$6.92M | -$4.06M | -$3.15M |
| EPS Diluted | -$0.12 | -$0.15 | -$0.09 | -$0.08 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Anavex Life Sciences Corp. · CIK 1314052 · Engraved from SEC EDGAR
ended Dec 31, 2019 · filed Feb 6, 2020 · 37 d after period end
